AGA Institute is seeking public comment on a new guideline for the management of gastric intestinal metaplasia (GIM). This guideline focuses on recommendations for the management of patients with GIM detected as part of routine upper endoscopy for reasons including workup of endoscopically identified gastropathy/presumed gastritis, dyspepsia or exclusion of H. pylori. Screening for gastric cancer (either population-wide or in select populations), management of patients with dysplasia of the gastric mucosa, management of patients with gastric adenocarcinoma, and diagnostic endoscopy in patients with symptoms are beyond the scope of this current guideline.
Review and submit feedback by June 6
AGA Institute is seeking public comment on the clinical practice guideline and technical review for the recommendations on the management of patients with GIM.
Please review the following documents:
Submit your comments by completing this survey. The public comment period will end at noon EDT on Thursday, June 6.
Learn more about AGA’s clinical practice guidelines.
